HomeNNNN • NASDAQ
add
Anbio Biotechnology
Previous close
$28.43
Day range
$26.93 - $29.50
Year range
$6.05 - $55.65
Market cap
1.20B USD
Avg Volume
30.95K
P/E ratio
185.98
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.03M | 73.93% |
Operating expense | 455.00K | -74.57% |
Net income | 1.30M | 312.91% |
Net profit margin | 64.14 | 222.40% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.90M | 1.19% |
Total assets | 30.24M | 59.83% |
Total liabilities | 87.84K | -94.92% |
Total equity | 30.16M | — |
Shares outstanding | 43.89M | — |
Price to book | 41.20 | — |
Return on assets | 9.92% | — |
Return on capital | 9.95% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.30M | 312.91% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2021
Website
Employees
27
